{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-22-000103","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2022-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.128382+00:00","generated_at":"2026-06-22T22:01:02.777521+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q3 organic sales +9.9% to $4.5B; adj EPS $2.12 -3.6%; guides FY adj EPS $9.15-$9.25","bullets":["Net sales $4.5B (+7.7% reported, +9.9% organic); MedSurg & Neuro +10.8% organic, Ortho & Spine +8.7%.","Reported EPS $2.14 (+87.7%); adjusted EPS $2.12 (-3.6%); adjusted operating margin 22.3% (-310 bps).","FY 2022 organic net sales growth guidance raised to 8.5%-9.0%; currency to hit sales ~4% and adj EPS $0.35-$0.40.","Adjusted EPS guidance narrowed to $9.15-$9.25 from prior view, citing inflation and FX headwinds.","CEO cites strong capital equipment order book and sales momentum despite product shortages."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-22-000103","json":"https://secwatch.observer/filing/0000310764-22-000103.json","markdown":"https://secwatch.observer/filing/0000310764-22-000103.md","text":"https://secwatch.observer/filing/0000310764-22-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000103/0000310764-22-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000103/syk-20221031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:01:02.777521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"523e69d2bef8fe3ca048e8b4b89e2968ca549686","claim":"STRYKER CORP reported third quarter of 2022 results: revenue $4.5 billion, net income $816 million, EPS $2.14. Guidance lowered.","evidence_excerpt":"Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results • Reported net sales increased 7.7% to $4.5 billion • Organic net sales increased 9.9% • Reported operating income margin of 18.0% • Adjusted operating income margin (1) contracted 310 bps to 22.3% • Reported EPS increased 87.7% to $2.14 • Adjusted EPS (1) decreased 3.6% to $2.12","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000103/0000310764-22-000103-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of 2022"},{"label":"Revenue","value":"$4.5 billion"},{"label":"Net income","value":"$816 million"},{"label":"EPS","value":"$2.14"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}